OCR Text |
Show Clinical Correspondence Section Editors: Robert Avery, DO Karl C. Golnik, MD Caroline Froment, MD, PhD An-Guor Wang, MD Bilateral Posterior Cerebral Artery Stroke from COVIDRelated Multisystem Inflammatory Syndrome in a Child Samuel W. Wilkinson, MD, Tyler Etheridge, MD, Cole J. Swiston, MD, Sravanthi Vegunta, MD, Richard H. Wiggins, MD, Judith E. A. Warner, MD S evere acute respiratory syndrome coronavirus 2 (SARSCoV-2) infection can cause multisystem inflammatory syndrome in children (MIS-C). MIS-C and severe SARSCoV-2 infections have been associated with thrombotic events (1) and mild-to-severe neurologic conditions, including strokes (2). Beslow et al found that 8 of 971 (0.82%) hospitalized pediatric patients with SARS-CoV-2 infection suffered from ischemic stroke (3). Multiple cases of middle cerebral artery stroke have been published. Two cases of bilateral posterior cerebral artery (PCA) stroke in patients with MIS-C have been published. One PCA stroke case involved a 10-year-old boy in Egypt whose information is included in an international survey, but a detailed case report cannot be found (3). The second was a 2-monthold boy on extracorporeal membrane oxygenation (ECMO) —an intervention with known risk of thrombosis (4,5). To the best of our knowledge, this is the first case report of bilateral PCA stroke in a MIS-C patient not on ECMO. A previously healthy 12-year-old girl arrived at the emergency department with fever, abdominal pain, and laboratory evidence of severe inflammation (CRP 21.5 mg/ dL, ESR 44 mm/hr, fibrinogen 566 mg/dL, D-dimer 7.93 mg FEU/mL, and ferritin 1,681 ng/mL), multisystem dysfunction (troponin 0.09 ng/mL, BNP 284 pg/mL, creatinine 0.92 mg/dL, BUN 23 mg/dL, AST 72 unit/L, and ALT 97 unit/L), and SARS-CoV-2 infection (positive SARS-CoV-2 by PCR [Cepheid] and SARS-CoV-2 IgG Antibody [Abbott, Abbott Park, IL]). Her medical, surgical, and family history were unremarkable. The patient acutely decompensated in the emergency department. Given concerns for an acute abdomen, exploratory laparotomy was performed, but was unremarkable, except for bilious fluid throughout her abdoDepartment of Ophthalmology and Visual Sciences (SW, TE, CS, SV, JEAW), John A Moran Eye Center, Salt Lake City, Utah; and Department of Radiology and Imaging Sciences (RHW), University of Utah, Salt Lake City, Utah. Supported in part by an Unrestricted Grant from Research to Prevent Blindness, New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah. The authors report no conflicts of interest. Address correspondence to Samuel Wilkinson, MD, Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132; E-mail: sam.wilkinson@hsc.utah.edu e548 men. She had less than 5 milliliters of blood loss. The patient remained intubated and sedated and became hypotensive, requiring vasopressor support in the pediatric intensive care unit. Echocardiography showed mildly decreased left ventricular function. Rheumatology and infectious disease were consulted, and treatment for presumed MIS-C was started with intravenous immunoglobulin, anakinra 200 mg, intravenous methylprednisolone 40 mg twice daily, aspirin 81 mg daily, and enoxaparin 36 mg twice daily. Vasopressors were weaned on Day 3. On Day 4, the patient returned to the operating room for delayed abdominal closure and was extubated on room air. She was transitioned to oral prednisone 40 mg twice daily with down trending inflammatory markers on Day 5. Repeat echocardiography on Day 7 showed normal left ventricular function. The patient was discharged on Day 8 on aspirin 81 mg daily and prednisone 40 mg twice daily. On Day 9, the patient’s mother offered her gummy bears from her right side; however, the patient did not notice and had to be verbally prompted to reach for the food. Later, her mother attempted to hand the patient a remote from above her head, and she did not notice. The patient had blurry vision during her initial hospitalization; however, further evaluation was not performed, as her decreased vision was believed to be related to sedation. The patient reported that she had persistent peripheral vision loss, which prompted her mother to take her back to the emergency department. On examination in the emergency department, her visual acuity was 20/20 in both eyes. Her intraocular pressures were 23 and 20 mm Hg in the right and left eyes, respectively. Pupils in light were 7 mm bilaterally and sluggishly reactive to light. She had no relative afferent pupillary defect. She had full extraocular movements and was orthophoric. Visual field testing using red targets showed symmetric bilateral superior hemifield defects. She had normal color vision. Anterior segment examination was normal. Posterior segment examination showed normal optic nerves with a cup-to-disc ratio of 0.1, normal macula, vessels, and peripheries. Virtual visual fields (Virtual Field —a technology with ongoing validation studies) were obtained at the bedside and demonstrated a dense superior altitudinal defect and nasal step bilaterally with partial inferotemporal defect of the right eye and inferonasal step of the left eye (Fig. 1) (6). Visual field defects were confirmed with automated visual field. Complete neurological examination was otherwise normal. Wilkinson et al: J Neuro-Ophthalmol 2022; 42: e548-e550 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Clinical Correspondence Given concern for bilateral PCA strokes, MRI of the brain with contrast and MRA of the head and neck were obtained. The MRA of the brain showed posterior circulation arterial ischemic strokes involving the bilateral PCA and hippocampal arteries. The imaging was suggestive of focal cerebral arteriopathy–inflammatory subtype, involving the bilateral P1 and proximal P2 segments, likely related to SARS-CoV-2 and MIS-C (Fig. 2). The patient was discharged home with continuation of prednisone 40 mg twice daily and aspirin 81 mg daily with neurology and neuro-ophthalmology follow-up. At follow-up 4 weeks later, her deficits were unchanged. In summary, our patient is a previously healthy 12-yearold girl with recent hospital admission for MIS-C with gastrointestinal and cardiac involvement with exploratory laparotomy. She presented to the emergency department 1 day after discharge with complaints of visual field deficits. She was found to have arterial ischemic strokes involving the bilateral PCA and hippocampal arteries believed to be secondary to SARS-CoV-2 and MIS-C. She had no other risk factors for ischemic stroke, including no evidence of thrombosis on echocardiography, hematologic conditions, arteriovenous malformation, history of genetic syndromes or metabolic disorders associated with stroke, history of cancer, trauma, inciting drugs, or vasculitis. The hemodynamic instability during her exploratory laparotomy was brief, and imaging was not typical for systemic hypotension. FIG. 1. Selected images from a virtual visual field (virtual field) obtained at the bedside. Right eye visual field (right) showed good reliability, dense superior altitudinal defect, and nasal step with an inferotemporal defect. Left eye visual field (left) showed good reliability, dense superior altitudinal defect, and inferior nasal step. Overall, she has a congruous left superior quadrantanopia and an incongruous right homonymous hemianopia. Wilkinson et al: J Neuro-Ophthalmol 2022; 42: e548-e550 FIG. 2. Selected images from an MRI of the brain. Axial correlating DWI (A), ADC (B), and FLAIR (C) images demonstrate restricted diffusion within the bilateral medial occipital lobes with bright DWI signal intensity (A, arrows), and dark ADC signal intensity (B, arrows), consistent with restricted diffusion, and abnormally correlating bright T2/FLAIR signal intensity (C, arrows), consistent with ischemia most likely greater than 6 hours and less than 10 days in age. Superior to inferior collapsed view of the 3D TOF MRA sequence demonstrates focal narrowing of the bilateral PCA vessels (D, arrows) near the P2/3 junction on the left and the P3 segment on the right. Hypotension would also not result in the focal arteriopathy. There were no features to suggest embolic source. Although the underlying etiology for thrombosis in SARS-CoV-2 is poorly understood, Hanff et al propose 5 underlying mechanisms for hypercoagulability that could explain this patient’s outcome, including disseminated intravascular coagulation, cytokine storm, complement activation, macrophage activation syndrome and hyperferritinemia, and renin–angiotensin system overactivation.1 Although rare, this case highlights 1 of the severe, potentially vision-threatening complications of pediatric SARSCoV-2 infection. More research is needed to evaluate the best management in pediatric SARS-CoV-2 infection and MIS-C patients. STATEMENT OF AUTHORSHIP Category 1: a. Conception and design: N/A; b. Acquisition of data: S. Wilkinson, T. Etheridge, C. Swiston, S. Vegunta, R. H. Wiggins, and J. E. A. Warner; c. Analysis and interpretation of data: R. H. Wiggins. Category 2: a. Drafting the manuscript: S. Wilkinson, T. Etheridge, C. Swiston, and S. Vegunta; b. Revising it for intellectual content: R. H. e549 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Clinical Correspondence Wiggins and J. E. A. Warner. Category 3: a. Final approval of the completed manuscript: S. Wilkinson, T. Etheridge, C. Swiston, S. Vegunta, R. H. Wiggins, and J. E. A. Warner. 3. REFERENCES 1. Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95:1578–1589. 2. Larovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, Walker TC, Singh AR, Dapul H, Hobbs CV, McLaughlin GE, Son MBF, Maddux AB, Clouser KN, Rowan CM, McGuire JK, Fitzgerald JC, Gertz SJ, Shein SL, Munoz AC, Thomas NJ, Irby K, Levy ER, Staat MA, Tenforde MW, Feldstein LR, Halasa NB, Giuliano JS, Hall MW, Kong M, Carroll CL, Schuster JE, Doymaz S, Loftis LL, Tarquinio KM, Babbitt CJ, Nofziger RA, Kleinman LC, Keenaghan MA, Cvijanovich NZ, Spinella PC, Hume JR, Wellnitz K, Mack EH, Michelson KN, Flori HR, Patel MM, Randolph AG. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 e550 4. 5. 6. or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536–547. Beslow LA, Linds AB, Fox CK, Kossorotoff M, Zuñiga Zambrano YC, Hernández-Chávez M, Hassanein SMA, Byrne S, Lim M, Maduaka N, Zafeiriou D, Dowling MM, Felling RJ, Rafay MF, Lehman LL, Noetzel MJ, Bernard TJ, Dlamini N. Pediatric ischemic stroke: an infrequent complication of SARS-CoV-2. Ann Neurol. 2021;89:657–665. Schupper AJ, Yaeger KA, Morgenstern PF. Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Child’s Nerv Syst. 2020;36:1579–1580. Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost. 2018;44:20–29. Chiang H, Hoang A, Waldman C, Rubin JM. Comparison of a Virtual Reality Visual Field Program to the Zeiss Humphrey 24-2 Sita Standard in a Comprehensive Ophthalmology Practice. Electronic Poster Presented at: The Virtual Annual Meeting of the American Society of Cataract and Refractive Surgeons. Available at: https://ascrs.confex.com/ascrs/20am/meetingapp.cgi/ Paper/61842. Accessed July 12, 2021. Wilkinson et al: J Neuro-Ophthalmol 2022; 42: e548-e550 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. |
References |
1. Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95:1578-1589. 2. Larovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, Walker TC, Singh AR, Dapul H, Hobbs CV, McLaughlin GE, Son MBF, Maddux AB, Clouser KN, Rowan CM, McGuire JK, Fitzgerald JC, Gertz SJ, Shein SL, Munoz AC, Thomas NJ, Irby K, Levy ER, Staat MA, Tenforde MW, Feldstein LR, Halasa NB, Giuliano JS, Hall MW, Kong M, Carroll CL, Schuster JE, Doymaz S, Loftis LL, Tarquinio KM, Babbitt CJ, Nofziger RA, Kleinman LC, Keenaghan MA, Cvijanovich NZ, Spinella PC, Hume JR, Wellnitz K, Mack EH, Michelson KN, Flori HR, Patel MM, Randolph AG. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536-547. 3. Beslow LA, Linds AB, Fox CK, Kossorotoff M, Zuñiga Zambrano YC, Hernández-Chávez M, Hassanein SMA, Byrne S, Lim M, Maduaka N, Zafeiriou D, Dowling MM, Felling RJ, Rafay MF, Lehman LL, Noetzel MJ, Bernard TJ, Dlamini N. Pediatric ischemic stroke: an infrequent complication of SARS-CoV-2. Ann Neurol. 2021;89:657-665. 4. Schupper AJ, Yaeger KA, Morgenstern PF. Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Child's Nerv Syst. 2020;36:1579-1580. 5. Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost. 2018;44:20-29. 6. Chiang H, Hoang A, Waldman C, Rubin JM. Comparison of a Virtual Reality Visual Field Program to the Zeiss Humphrey 24-2 Sita Standard in a Comprehensive Ophthalmology Practice. Electronic Poster Presented at: The Virtual Annual Meeting of the American Society of Cataract and Refractive Surgeons. Available at: https://ascrs.confex.com/ascrs/20am/meetingapp.cgi/Paper/61842 . Accessed July 12, 2021. |